Cencora, Inc. · NYSE:COR
Cencora — AmerisourceBergen — Q3 FY2017 Earnings Presentation
14 slides from Cencora's earnings presentation, Aug 3, 2017
Slide 1: Q3 FY2017 Financial Results
Q3 FY2017 Financial Results August 3, 2017
Slide 2: Cautionary Note Regarding Forward-Looking Statements
Cautionary Note Regarding Forward-Looking Statements Certain of the statements contained in this presentation are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Words such as "expect," "likely," "ou
Slide 3: AmerisourceBergen is creating healthier futures
AmerisourceBergen is creating healthier futures • Shaping healthcare delivery through knowledge, reach and partnership • Providing industry leading services and solutions that improve product access, increase supply chain efficiency and enhance patient care 3
Slide 4: Highly Differentiated & Strongly Positioned for Growth
Highly Differentiated & Strongly Positioned for Growth Customer Base Innovative Services & • Key anchor customers Solutions • Fast growing • Customer-focused offerings serving • U.S. Pharmaceutical focus manufacturers and provider customers Leadership in Specialty Successful Financial Distribution &
Slide 5: Q3 FY2017 Financial Results: Overview
Q3 FY2017 Financial Results: Overview ▪ AmerisourceBergen continues to execute in a dynamic healthcare market - Continued to lead the market in specialty services and distribution - Delivered strong growth across Consulting Services, MWI Animal Health and World Courier - Corporate reorganization und
Slide 6: Q3 FY2017 Financial Results
Q3 FY2017 Financial Results Adjusted GAAP (Non-GAAP)1 Revenue $38.7B $38.7B % Change (Year over Year) 4.9% 4.9% Gross Profit $1.1B $1.1B % Change (2.5)% (1.1)% Operating Expenses $909M $584M % Change 57.0% 2.1% Operating Income $170M $471M % Change (67.8)% (4.9)% Interest Expense, Net $36M $35M % Ch
Slide 7: Pharmaceutical Distribution Services Segment
Q3 FY2017 Financial Results: Pharmaceutical Distribution Services Segment Q3 FY2017 Q3 FY2016 Revenue $37.0B $35.4B Operating Income $377M $413M Percentages of Revenue Gross Profit 2.05% 2.25% Operating Expenses 1.03% 1.08% Operating Income 1.02% 1.17% Large anchor customers continue to grow in li
Slide 8: Other Businesses – Global Commercialization Services and Animal Health
Q3 FY2017 Financial Results: Other Businesses – Global Commercialization Services and Animal Health Q3 FY2017 Q3 FY2016 Revenue $1.7B $1.6B Operating Income $95M $83M Percentages of Revenue Gross Profit 16.98% 17.31% Operating Expenses 11.55% 12.07% Operating Income 5.43% 5.23% Other includes Worl
Slide 9: FY2017 Financial Guidance
FY2017 Financial Guidance1 Expectations on an Adjusted (Non-GAAP) Basis Revenue Growth ~5% Adjusted Diluted Earnings Per Share $5.82 to $5.92 Adjusted Operating Expense Growth 2% to 3% Adjusted Operating Income ~Flat Adjusted Effective Tax Rate ~31% Free Cash Flow $750M to $1B Capital Expenditures ~
Slide 10: Appendix
Appendix N) AmerisourceBergen’
Slide 11: Appendix
Appendix Note: For more information related to non-GAAP financial measures, refer to the section titled “Supplemental Information Regarding Non-GAAP Financial Measures” of the Company’s most recent Current Report on Form 8-K furnished under Item 2.02. 11
Slide 12: Appendix
Appendix Note: For more information related to non-GAAP financial measures, refer to the section titled “Supplemental Information Regarding Non-GAAP Financial Measures” of the Company’s most recent Current Report on Form 8-K furnished under Item 2.02. 12
Slide 13: Appendix
Appendix Note: For more information related to non-GAAP financial measures, refer to the section titled “Supplemental Information Regarding Non-GAAP Financial Measures” of the Company’s most recent Current Report on Form 8-K furnished under Item 2.02. 13
Slide 14: AmerisourceBergen: Where knowledge, reach and partnership shape healthcare delivery
N) AmerisourceBergen’ Where knowledge, reach and partnership shape healthcare delivery.